Skip navigation.

Depo-Provera: Old Concerns, New Risks

By Amy Oliver and Diana Dukhanova

CLICK HERE TO DOWNLOAD DOCUMENT.

Contact us if you would like a free hard copy mailed.

The Summer 2000 issue of DifferenTakes provided an introductory glance at the injectable contraceptive Depo-Provera (or DMPA), and why many women's health advocates are concerned with its use and misuse around the world. Approved for use in the U.S. in 1992, Depo has only become more controversial as its image as a hassle-free contraceptive clashes with the reality of possible side effects such as irregular bleeding, weakness, depression, weight gain, nausea, loss of libido, darkening of skin, abdominal pain, headaches and hair loss. Side effects can be so numerous and severe that over 70% of American women who have ever used Depo discontinued their use within the first year. Injected into the arm or buttock, Depo's effects last for three months and its effectiveness rate is an impressive 99.7%. But with alarming new risks added to these worrisome side effects, the contraceptive deserves closer scrutiny.

Amy Oliver is the Program Coordinator for the Population and Development Program at Hampshire College, an organization dedicated to promoting reproductive rights, economic justice, and social equality for women. Diana Dukhanova is a fourth-year student at Hampshire College concentrating in Russian literature. She has been working for the Civil Liberties and Public Policy Program and Population and Development Program since her first year and her primary activist interests lie in reproductive rights.